Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Transmission Study Group.
Cooper ER, Nugent RP, Diaz C, Pitt J, Hanson C, Kalish LA, Mendez H, Zorrilla C, Hershow R, Moye J, Smeriglio V, Fowler MG. Cooper ER, et al. Among authors: nugent rp. J Infect Dis. 1996 Dec;174(6):1207-11. doi: 10.1093/infdis/174.6.1207. J Infect Dis. 1996. PMID: 8940210
The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Korelitz J, Meyer WA 3rd, Bethel J, Rich K, Pahwa S, Moye J Jr, Nugent R, Read J. Mofenson LM, et al. J Infect Dis. 1997 May;175(5):1029-38. doi: 10.1086/516441. J Infect Dis. 1997. PMID: 9129063 Clinical Trial.
Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.
Stiehm ER, Lambert JS, Mofenson LM, Bethel J, Whitehouse J, Nugent R, Moye J Jr, Glenn Fowler M, Mathieson BJ, Reichelderfer P, Nemo GJ, Korelitz J, Meyer WA 3rd, Sapan CV, Jimenez E, Gandia J, Scott G, O'Sullivan MJ, Kovacs A, Stek A, Shearer WT, Hammill H. Stiehm ER, et al. J Infect Dis. 1999 Mar;179(3):567-75. doi: 10.1086/314637. J Infect Dis. 1999. PMID: 9952362 Clinical Trial.
Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Moye J Jr, Korelitz J, Bethel J, Hirschhorn R, Nugent R. Mofenson LM, et al. Pediatr Infect Dis J. 1994 Jun;13(6):477-84. doi: 10.1097/00006454-199406000-00003. Pediatr Infect Dis J. 1994. PMID: 8078734 Clinical Trial.
Serum vitamin A concentrations in a North American cohort of human immunodeficiency virus type 1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Read JS, Bethel J, Harris DR, Meyer WA 3rd, Korelitz J, Mofenson LM, Moye J Jr, Pahwa S, Rich K, Nugent RP. Read JS, et al. Among authors: nugent rp. Pediatr Infect Dis J. 1999 Feb;18(2):134-42. doi: 10.1097/00006454-199902000-00010. Pediatr Infect Dis J. 1999. PMID: 10048685
Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Moye J Jr, Bethel J, Hirschhorn R, Jordan C, Nugent R. Mofenson LM, et al. JAMA. 1992 Jul 22-29;268(4):483-8. doi: 10.1001/jama.268.4.483. JAMA. 1992. PMID: 1352363 Clinical Trial.
Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Bethel J, Moye J Jr, Flyer P, Nugent R. Mofenson LM, et al. J Acquir Immune Defic Syndr (1988). 1993 Oct;6(10):1103-13. J Acquir Immune Defic Syndr (1988). 1993. PMID: 8105072 Clinical Trial.
54 results